RESUMEN
BACKGROUND: Open Abdomen (OA) cases represent a significant surgical and resource challenge. AbClo is a novel non-invasive abdominal fascial closure device that engages lateral components of the abdominal wall muscles to support gradual approximation of the fascia and reduce the fascial gap. The study objective was to assess the economic implications of AbClo compared to negative pressure wound therapy (NPWT) alone on OA management. METHODS: We conducted a cost-minimization analysis using a decision tree comparing the use of the AbClo device to NPWT alone among patients with midline laparotomy for trauma or acute abdominal surgery who were ineligible for primary fascial closure. The time horizon was limited to the length of the inpatient hospital stay, and costs were considered from the perspective of the US Medicare payer. Clinical effectiveness data for AbClo was obtained from a randomized clinical trial. Cost data was obtained from the published literature. Probabilistic and deterministic sensitivity analyses were performed. The primary outcome was incremental cost. RESULTS: The mean cumulative costs per patient were $76 582 for those treated with NPWT alone and $70,582 for those in the group treated with the AbClo device. Compared to NPWT alone, AbClo was associated with lower incremental costs of -$6012 (95% CI -$19 449 to +$1996). The probability that AbClo was cost-savings compared to NPWT alone was 94%. CONCLUSIONS: The use of AbClo is an economically attractive strategy for management of OA in in patients with midline laparotomy for trauma or acute abdominal surgery who were ineligible for primary fascial closure.
Asunto(s)
Técnicas de Cierre de Herida Abdominal , Terapia de Presión Negativa para Heridas , Humanos , Terapia de Presión Negativa para Heridas/economía , Terapia de Presión Negativa para Heridas/métodos , Terapia de Presión Negativa para Heridas/instrumentación , Técnicas de Cierre de Herida Abdominal/economía , Técnicas de Cierre de Herida Abdominal/instrumentación , Fasciotomía/economía , Traumatismos Abdominales/cirugía , Traumatismos Abdominales/economía , Análisis Costo-Beneficio , Estados Unidos , Laparotomía/economía , Técnicas de Abdomen Abierto/economíaRESUMEN
To evaluate the effect of the open abdomen (OA) and closed abdomen (CA) approaches for treating intestinal fistula with complicated intra-abdominal infection (IFWCIAI), and analyze the risk factors in OA treatment.IFWCIAI is associated with high mortality rates and healthcare costs, as well as longer postoperative hospital stay. However, OA treatment has also been linked with increased mortality and development of secondary intestinal fistula.A total of 195 IFWCIAI patients who were operated over a period of 7 years at our hospital were retrospectively analyzed. These patients were divided into the OA group (nâ=â112) and CA group (nâ=â83) accordingly, and the mortality rates, hospital costs, and hospital stay duration of both groups were compared. In addition, the risk factors in OA treatment were also analyzed.OA resulted in significantly lower mortality rates (9.8% vs 30.1%, Pâ<â.001) and hospital costs ($11721.40â±â$9368.86 vs $20365.36â±â$21789.06, Pâ<â.001) compared with the CA group. No incidences of secondary intestinal fistula was recorded and the duration of hospital stay was similar for both groups (Pâ=â.151). Delayed OA was an independent risk factor of death following OA treatment (hazard ratio [HR]â=â1.316; 95% confidence interval [CI]â=â1.068-1.623, Pâ=â.010), whereas early enteral nutrition (EN) exceeding 666.67âmL was a protective factor (HRâ=â0.996; 95% CIâ=â0.993-0.999, Pâ=â.018). In addition, Acinetobacter baumannii, Pseudomonas aeruginosa, and Candida albicans were the main pathogens responsible for the death of patients after OA treatment.OA decreased mortality rates and hospital costs of IFWCIAI patients, and did not lead to any secondary fistulas. Early OA and EN also reduced mortality rates.